UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 10-Q/A
Amendment No. 1
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2002
Commission File Number 1-10827
PHARMACEUTICAL RESOURCES, INC.
(Exact name of registrant as specified in its charter)
NEW JERSEY 22-3122182
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
ONE RAM RIDGE ROAD, SPRING VALLEY, NEW YORK 10977
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (845) 425-7100
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding twelve months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes T No ___
32,492,490
Number of shares of Common Stock outstanding as of August 9, 2002.
Item 6. Exhibits and Reports on Form 8-K.
- ------- ---------------------------------
(a) Exhibits:
10.38 Patent and Know How License Agreement dated May 24, 2002 among
Nortec Development Associates, Inc. and Par Pharmaceutical,
Inc.*
10.39 Amendment No. 1 to the Patent and Know How License Agreement
dated May 24, 2002 among Nortec Development Associates, Inc.
and Par Pharmaceutical, Inc.*
10.40 Patent and Know How License Agreement dated June 14, 2002 among
Nortec Development Associates, Inc. and Par Pharmaceutical,
Inc.*
* Certain portions of this exhibit have been omitted and have been
filed with the SEC pursuant to a request for confidential treatment
thereof.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
PHARMACEUTICAL RESOURCES, INC.
------------------------------
(Registrant)
October 21, 2002 /s/ Kenneth I. Sawyer
---------------------------------------
Kenneth I. Sawyer
Chief Executive Officer and Chairman of
the Board of Directors
(Principal Executive Officer)
October 21, 2002 /s/ Dennis J. O'Connor
---------------------------------------
Dennis J. O'Connor
Vice President - Chief Financial
Officer and Secretary
(Principal Accounting and Financial
Officer)
EXHIBIT INDEX
Exhibit Number Description Page Number
-------------- ----------- -----------
10.38 Patent and Know How License Agreement dated May 24, 2002 among
Nortec Development Associates, Inc. and Par Pharmaceutical, Inc.*
10.39 Amendment No. 1 to the Patent and Know How License Agreement
dated May 24, 2002 among Nortec Development Associates, Inc. and
Par Pharmaceutical, Inc.*
10.40 Patent and Know How License Agreement dated June 14, 2002 among
Nortec Development Associates, Inc. and Par Pharmaceutical, Inc.*
* Certain portions of this exhibit have been omitted and have been
filed with the SEC pursuant to a request for confidential treatment
thereof.